维普中文期刊产品整合服务
11篇 您的检索式:作者名="HIRANE M"
    题名 作者 年代 出处 被引量
1Lysophos- phatidic acid receptors in cancer pathobiology 显示文摘TSUJIUCHI T ARAKI M HIRANE M 2014Histol His- topathol2014,29,3:1
2Wet spun chitosan-collagen fibers , their chemical N-modifications, and blood compatibility 显示文摘Hirane S Zhang M Nakagawa M 2000Biomaterials2000,21,10:1
3Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells 显示文摘ISHII S HIRANE M FUKUSHIMA Kaori 2015Biochem Biophys Res Commun2015,461,1:1
4Lysophospha- tidic acid receptor-5 negatively regulates cell motile and inva- sire activities of human sarcoma cell lines 显示文摘DONG Yan HIRANE M ARAKI M 2014Mol Cell Bio- chem2014,393,12:1
5Wet spun chitosan-collagen fibers,their chemical N-modifications,and blood com-patibility显示文摘Hirane S Zhang Min Nakagawa M 2000Biomaterials2000,21,10:1
6Wet spun chitosan collagen fibers,their chemical modification,and blood compatibility显示文摘Hirane S Zhang M Nakagawa M 2000Biomaterials2000,,21:1
7Role of bronchial artery embolization in the management of hemoptysis显示文摘Femando Hiran C Stein M Benfield J R 1998Arch Surg1998,133,:1
8Effects of endosul- fan on brain acetylcholinesterase activity in juvenile blue gill sunfish显示文摘Hiran M Dutta Dane A Arends 2003Environmental Research2003,91,3:1
9Wet-spun chitosan-collagen fibers,their chemical modifications,and bloodcompatibility显示文摘HIRANE S ZHANG Min NAKAGAWA M 2000Biomaterials2000,,21:1
10Wet spun chitosan collagen fibers, their chemical modification, and blood compatibility 显示文摘Hirane S Zhang M Nakagawa M 2000Biomaterials2000,,21:1
11Fibrin sealant for esophageal anastomosis:A phase II study显示文摘BACKGROUND Esophagectomy is a pivotal curative modality for localized esophageal or esophagogastric junction cancer(EC or EJC).Postoperative anastomotic leakage(AL)remains problematic.The use of fibrin sealant(FS)may improve the strength of esophageal anastomosis and reduce the incidence of AL.AIM To assess the efficacy and safety of applying FS to prevent AL in patients with EC or EJC.METHODS In this single-arm,phase II trial(Clinicaltrial.gov identifier:NCT03529266),we recruited patients aged 18-80 years with resectable EC or EJC clinically staged as T1-4aN0-3M0.An open or minimally invasive McKeown esophagectomy was performed with a circular stapled anastomosis.After performing the anastomosis,2.5 mL of porcine FS was applied circumferentially.The primary endpoint was the proportion of patients with AL within 3 mo.RESULTS From June 4,2018,to December 29,2018,57 patients were enrolled.At the data cutoff date(June 30,2019),three(5.3%)of the 57 patients had developed AL,including two(3.5%)with esophagogastric AL and one(1.8%)with gastric fistula.The incidence of anastomotic stricture and other major postoperative complications was 1.8%and 17.5%,respectively.The median time needed to resume oral feeding after operation was 8 d(Interquartile range:7.0-9.0 d).No adverse events related to FS were recorded.No deaths occurred within 90 d after surgery.CONCLUSION Perioperative sealing with porcine FS appears safe and may prevent AL after esophagectomy in patients with resectable EC or EJC.Further phase III studies are warranted.Yao-Bin Lin Jian-Hua Fu Yan Huang Yi-Huai Hu Kong-Jia Luo Ke-Xi Wang AmosÉla Bella Dong-Rong Situ Ji-Yang Chen Ting Lin Xavier B D’Journo Nuria M Novoa Alessandro Brunelli Hiran C Fernando Robert J Cerfolio Mahmoud Ismail Hong Yang 2020World Journal of Gastrointestinal Oncology2020,12,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费